Overview

Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to compare the pharmacokinetic (PK) response after inhaled insulin administration with 3 different inhalation regimens and with subcutaneous insulin administration.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Dance Biopharm Inc.
Treatments:
Insulin
Insulin Lispro
Insulin, Globin Zinc